Investor Presentaiton
Statement of profit or loss
marino
med
€m
H1 2020
H1 2019
Revenue €m
H1 2020
H1 2019
Revenues
1
Sale of goods
2.0
1.5
2.3
1.7
License revenues
0.1
0.0
Other income
0.5
0.3
Other revenues
0.1
0.2
Other net gains/losses
(0.0)
0.0
Total revenue
2.3
1.7
Materials expenses
(1.6)
(1.1)
Services expenses
2
(1.0)
(1.6)
2 R&D expenses €m
H1 2020
H1 2019
Personnel expenses
(2.0)
(2.0)
Personnel expenses
(0.9)
(0.6)
Depreciation and amortisation
(0.2)
(0.2)
Services expenses
(3
(0.7)
(1.3)
Other expenses
(0.9)
(1.1)
Materials expenses
(0.1)
(0.1)
Other expenses*
(0.5)
(0.4)
Operating result (EBIT)
(2.9)
(4.1)
Total R&D expenses
(2.2)
(2.4)
Financial result
4
(0.3)
(0.8)
3
Profit/loss before taxes
(3.2)
(4.9)
Decrease due to forced delays of clinical studies due
to COVID-19 crisis
Taxes on income
(0.0)
(0.0)
4
Profit/loss for the period
(3.2)
(4.9)
Therein valuation of equity conversion right of the
convertible bond in the amount of €0.3m (2019)
and interest on shareholder loans as well as on
convertible bond of €0.4m (2019)
Note: *includes depreciation & amortization as well as financial expenses
19View entire presentation